In 2024, Monaco was the European country estimated to have the highest fertility rate. The country had a fertility rate of 2.1 children per woman. Other small countries such as Gibraltar or Montenegro also came towards the top of the list for 2024, while the large country with the highest fertility rate was France, with 1.64 children per woman. On the other hand, Ukraine had the lowest fertility rate, averaging around one child per woman.

In 2025, the total fertility rate in Europe was estimated to be 1.41 births per woman compared with 2.7 in 1950. The fertility rate in Europe fell considerably between 1957 and 1999, falling from 2.62 to 1.4.

Fertility rate, total (births per woman) in European Union was reported at 1.386 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. European Union - Fertility rate, total (births per woman) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The crude birth rate in Montenegro was estimated to be **** live births per 1,000 population in 2024, the highest among countries in Europe. By contrast, Ukraine had the lowest crude birth rate in Europe, at *** live births per 1,000 population.

Birth rate, crude (per 1,000 people) in European Union was reported at 8.1624 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. European Union - Birth rate, crude - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

Adolescent fertility rate (births per 1,000 women ages 15-19) in European Union was reported at 6.6626 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. European Union - Adolescent fertility rate (births per 1,000 women ages 15-19) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

The total fertility rate of the world has dropped from around 5 children per woman in 1950, to 2.2 children per woman in 2025, which means that women today are having fewer than half the number of children that women did 75 years ago. Replacement level fertility This change has come as a result of the global demographic transition, and is influenced by factors such as the significant reduction in infant and child mortality, reduced number of child marriages, increased educational and vocational opportunities for women, and the increased efficacy and availability of contraception. While this change has become synonymous with societal progress, it does have wide-reaching demographic impact - if the global average falls below replacement level (roughly 2.1 children per woman), as is expected to happen in the 2050s, then this will lead to long-term population decline on a global scale. Regional variations When broken down by continent, Africa is the only region with a fertility rate above the global average, and, alongside Oceania, it is the only region with a fertility rate above replacement level. Until the 1980s, the average woman in Africa could expect to have 6-7 children over the course of their lifetime, and there are still several countries in Africa where women can still expect to have 5 or more children in 2025. Historically, Europe has had the lowest fertility rates in the world over the past century, falling below replacement level in 1975. Europe's population has grown through a combination of migration and increasing life expectancy, however even high immigration rates could not prevent its population from going into decline in 2021.

For most of the past two centuries, falling birth rates have been associated with societal progress. During the demographic transition, where pre-industrial societies modernize in terms of fertility and mortality, falling death rates, especially among infants and children, are the first major change. In response, as more children survive into adulthood, women have fewer children as the need to compensate for child mortality declines. This transition has happened at different times across the world and is an ongoing process, with early industrial countries being the first to transition, and Sub-Saharan African countries being the most recent to do so. Additionally, some Asian countries (particularly China through government policy) have gone through their demographic transitions at a much faster pace than those deemed more developed. Today, in countries such as Japan, Italy, and Germany, birth rates have fallen well below death rates; this is no longer considered a positive demographic trend, as it leads to natural population decline, and may create an over-aged population that could place a burden on healthcare systems.

The statistic shows the 20 countries with the lowest fertility rates in 2024. All figures are estimates. In 2024, the fertility rate in Taiwan was estimated to be at 1.11 children per woman, making it the lowest fertility rate worldwide. Fertility rate The fertility rate is the average number of children born per woman of child-bearing age in a country. Usually, a woman aged between 15 and 45 is considered to be in her child-bearing years. The fertility rate of a country provides an insight into its economic state, as well as the level of health and education of its population. Developing countries usually have a higher fertility rate due to lack of access to birth control and contraception, and to women usually foregoing a higher education, or even any education at all, in favor of taking care of housework. Many families in poorer countries also need their children to help provide for the family by starting to work early and/or as caretakers for their parents in old age. In developed countries, fertility rates and birth rates are usually much lower, as birth control is easier to obtain and women often choose a career before becoming a mother. Additionally, if the number of women of child-bearing age declines, so does the fertility rate of a country. As can be seen above, countries like Hong Kong are a good example for women leaving the patriarchal structures and focusing on their own career instead of becoming a mother at a young age, causing a decline of the country’s fertility rate. A look at the fertility rate per woman worldwide by income group also shows that women with a low income tend to have more children than those with a high income. The United States are neither among the countries with the lowest, nor among those with the highest fertility rate, by the way. At 2.08 children per woman, the fertility rate in the US has been continuously slightly below the global average of about 2.4 children per woman over the last decade.

Niger had the highest birth rate in the world in 2024, with a birth rate of 46.6 births per 1,000 inhabitants. Angola, Benin, Mali, and Uganda followed. Except for Afghanistan, all 20 countries with the highest birth rates in the world were located in Sub-Saharan Africa. High infant mortality The reasons behind the high birth rates in many Sub-Saharan African countries are manyfold, but a major reason is that infant mortality remains high on the continent, despite decreasing steadily over the past decades, resulting in high birth rates to counter death rates. Moreover, many nations in Sub-Saharan Africa are highly reliant on small-scale farming, meaning that more hands are of importance. Additionally, polygamy is not uncommon in the region, and having many children is often seen as a symbol of status. Fastest-growing populations As the high fertility rates coincide with decreasing death rates, countries in Sub-Saharan Africa have the highest population growth rates in the world. As a result, Africa's population is forecast to increase from 1.4 billion in 2022 to over 3.9 billion by 2100.

The average for 2022 based on 195 countries was 18.38 births per 1000 people. The highest value was in Niger: 45.03 births per 1000 people and the lowest value was in Hong Kong: 4.4 births per 1000 people. The indicator is available from 1960 to 2022. Below is a chart for all countries where data are available.

In 2024, the birth rate in France reached its lowest level since 1982. From 1982 to 2019, the birth rate in France has been fluctuating between more than 11 births and almost 14 births for 1,000 inhabitants. For the first time in this period, the birth rate fell below 11 in 2020. The highest birth rate in France during this period was recorded in 1982. That year there were 14.8 births per 1,000 inhabitants. Since then, the birth rate in the country keeps decreasing. If France keeps being one of the European countries with the highest fertility rate, it is still been impacted by the decline in the birth rate that affects most Western countries. A Declining birth rate Birth rate is the ration between the annual number of live births and the average total population over that year. In 2023, there were 640,000 live births in France, while the French population amounted to 68 million people. The average number of children born per women went from 2.03 in 2010, down to 1.66 in 2023. Births in France With a crude birth rate of 10.9 births per 1,000 inhabitants in 2020, France still has one of the highest birth rates in Europe. The percentage of children born out-of-wedlock in France has been rising since the nineties, reaching 65.2 percent in 2022. Another change can be seen in the average age at childbirth among French women. In 2022, most of women in France were aged 31.1 years old at childbirth, compared to 28.8 years old in 1994.

Completeness of birth registration (%) in European Union was reported at 100 % in 2018, according to the World Bank collection of development indicators, compiled from officially recognized sources. European Union - Completeness of birth registration - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

Sex ratio at birth (male births per female births) in European Union was reported at 1.0559 in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. European Union - Sex ratio at birth (male births per female births) - actual values, historical data, forecasts and projections were sourced from the World Bank on September of 2025.

Snapshot img

Infertility Treatment Devices Market Size 2024-2028

The infertility treatment devices market size is forecast to increase by USD 682.6 billion at a CAGR of 6.7% between 2023 and 2028.

The market is experiencing significant growth due to several key factors. The prevalence of infertility is on the rise, driven by various lifestyle and health factors. Moreover, an emerging trend of delayed pregnancies among women is leading to a higher demand for infertility treatment devices. However, ethical, legal, and social concerns regarding infertility treatments pose challenges to market growth. These issues include ethical debates around the use of assisted reproductive technologies, legal regulations governing their use, and social stigma surrounding infertility and its treatments. Despite these challenges, the market is expected to continue growing as advancements in technology and increasing awareness of infertility issues drive innovation and demand for effective treatment solutions.

What will be the Size of the Infertility Treatment Devices Market During the Forecast Period?

Request Free Sample

The market encompasses a range of diagnostic and assisted reproductive technologies (ART), including in vitro fertilization (IVF), that aim to address infertility issues. The prevalence of infertility, driven by factors such as lifestyle changes, female fertility concerns, and conditions like polycystic ovary syndrome, continues to fuel market growth. ART operations, including fertility clinics, employ advanced technologies like microfluidic chip-based devices for sperm sorting and other procedures. Social and cultural implications, insurance coverage, and mobility constraints influence the market dynamics. Regulatory authorities closely scrutinize patent applications and the safety and efficacy of infertility treatment products. The incidence of infertility, driven by declining fertility rates, fuels the demand for these devices.Medical tourism also plays a role, with some individuals traveling to countries with more lenient regulations or lower costs. Assisted reproductive technology continues to evolve, offering new possibilities for those seeking to overcome infertility.

How is this Infertility Treatment Devices Industry segmented and which is the largest segment?

The infertility treatment devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductDevicesMediaAccessoriesGeographyAsiaSingaporeThailandNorth AmericaUSEuropeRest of World (ROW)

By Product Insights

The devices segment is estimated to witness significant growth during the forecast period.

The market is driven by several factors, including the rise in infertility prevalence, the success rate of infertility treatment procedures, investments in advanced IVF products, and increasing demand for technologically advanced devices. The devices segment is expected to dominate the market due to these factors, with geographical regions such as North America and Europe leading in market growth. The infertility rate in men and women, growing awareness about assisted reproductive technologies (ART), adoption of advanced technologies by healthcare authorities, and economic stability are key drivers In these regions. Infertility treatment devices, including sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, and incubators, are essential tools for ART procedures and are in high demand.

Get a glance at the Infertility Treatment Devices Industry report of share of various segments Request Free Sample

The Devices segment was valued at USD 825.60 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

Asia is estimated to contribute 49% to the growth of the global market during the forecast period.

Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The market in Asia is poised for growth due to several factors, including the rising prevalence of infertility, medical tourism, enhanced healthcare infrastructure, and increasing adoption of advanced technologies. The region's infertility rate is on the rise, attributed to lifestyle changes, the emergence of fertility-related diseases, and escalating stress levels. Infertility treatment devices, such as microfluidic chip-based devices for sperm sorting, are increasingly being adopted in fertility clinics to enhance success rates. Despite ethical and legal concerns regarding surrogacy and embryo transfers, Asia's infertility treatment market is gaining global recognition. The

Snapshot img

Fertility Services Market Size 2025-2029

The fertility services market size is forecast to increase by USD 9.53 billion, at a CAGR of 7.8% between 2024 and 2029.

The market is a continually evolving landscape, driven by various factors that shape its dynamics. One significant trend is the increasing demand for fertility treatments due to the rising prevalence of late parenthood. According to recent studies, the number of women giving birth over the age of 35 has increased by 23.3% in the last decade. This demographic shift has led to a surge in demand for assisted reproductive technologies, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Moreover, the market is also influenced by the growing incidence of prostate cancer, which can impact male fertility. According to the American Cancer Society, there will be approximately 193,000 new cases of prostate cancer diagnosed in the US in 2022.
This statistic underscores the importance of fertility services in addressing the reproductive health needs of cancer survivors. Despite these growth opportunities, the market faces challenges, including high complication rates associated with fertility treatments. For instance, the risk of multiple pregnancies and ovarian hyperstimulation syndrome (OHSS) are significant concerns. These complications can lead to increased healthcare costs and potential long-term health risks for patients. The market is a complex and dynamic industry, shaped by demographic trends, health concerns, and technological advancements. As the demand for fertility treatments continues to rise, stakeholders must navigate the challenges and opportunities that come with this evolving landscape.

Major Market Trends & Insights

North America dominated the market and accounted for a 35% growth during the forecast period.
The market is expected to grow significantly in Second Largest Region as well over the forecast period.
By the Service, the Treatment services sub-segment was valued at USD 6.65 billion in 2023
By the End-user, the Fertility clinics sub-segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 89.23 billion
Future Opportunities: USD USD 9.53 billion 
CAGR : 7.8%
North America: Largest market in 2023

What will be the Size of the Fertility Services Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

Fertility services encompass a range of medical interventions and technologies designed to help individuals and couples achieve pregnancy. One significant area within this market is the use of fertility medications, which play a crucial role in assisted reproductive technology (ART). According to recent reports, approximately 12% of women in the United States have used some form of fertility medication. ART involves various techniques, including artificial insemination, ovulation predictor kits, and ovarian stimulation protocols, among others. Cervical mucus plays a vital role in the natural process of conception, but ART may bypass this step through the use of intrauterine insemination (IUI) or in vitro fertilization (IVF).
In IUI, semen cryopreservation is essential for the success of the procedure. Ovarian stimulation protocols, such as ovulation induction, are commonly used in ART to increase the number of mature follicles and improve the chances of successful pregnancy. Ovulation predictor kits help individuals monitor their menstrual cycle and identify the most fertile days for conception. Despite the advancements in fertility services, challenges persist. Miscarriage rates remain a concern, with approximately 10-20% of known pregnancies ending in miscarriage. Blastocyst development is a critical factor in the success of ART, with implantation rate and pregnancy rate being essential indicators of treatment efficacy.
Reproductive endocrinology, a subspecialty of obstetrics and gynecology, focuses on the diagnosis and treatment of infertility. Donor insemination and ectopic pregnancy are other areas of fertility services that have gained increasing attention. Embryo culture media and ultrasound imaging are essential tools used in the field to monitor the development of embryos and assess the progress of pregnancies. Looking ahead, the market is expected to grow substantially. According to market reports, the global ART market is projected to expand at a significant rate, with an increase of around 15% in the number of ART cycles performed annually.
This growth is driven by factors such as rising infertility rates, increasing awareness, and advancements in technology. Comparing the growth rates of different regions, Asia Pacific is expected to witness the fastest growth in the ART market due to factors such as increasing disposable income, changing social norms, and government initiatives to promote fertility treatments

Snapshot img

Assisted Reproductive Technology Market Size 2024-2028

The assisted reproductive technology (ART) market size is forecast to increase by USD 6.3 billion at a CAGR of 4.36% between 2023 and 2028.

The market is experiencing significant growth due to the increasing rate of infertility cases, fertility supplements and the rising number of single-parent families. Infertility affects approximately 15% of couples worldwide, and this number is projected to increase. Additionally, the trend of single parenthood is on the rise, with over 30 million single parents in the United States alone. These demographic shifts are driving the demand for ART solutions, as they offer a viable option for individuals and couples seeking to start a family. However, the ART market also faces challenges. Side effects of infertility treatments, such as multiple pregnancies, ovarian hyperstimulation syndrome, and emotional stress, can deter potential patients.
These risks, coupled with the high cost of treatments, can limit market penetration. It is crucial for market players to address these challenges by investing in research and development of safer and more affordable ART solutions. By focusing on improving patient outcomes and reducing the financial burden, companies can capitalize on the growing demand for ART services and maintain a competitive edge in this dynamic market.

What will be the Size of the Assisted Reproductive Technology (ART) Market during the forecast period?

Request Free Sample

The market dynamics continue to evolve, driven by advancements in reproductive medicine and the expanding application across various sectors. Infertility treatment, a significant market segment, integrates ovulation induction, third-party reproduction, and hormonal therapy. Fertility preservation, another evolving area, encompasses donor eggs, egg retrieval, and embryo culture, catering to individuals undergoing medical treatments or choosing to delay parenthood. Stress and infertility are increasingly recognized as interconnected, leading to a growing emphasis on lifestyle modifications. Reproductive health concerns, such as chromosomal abnormalities and single gene disorders, are addressed through advanced diagnostic tools and reproductive surgery. Male infertility, a prevalent issue, is addressed through assisted hatching and sperm analysis.
Fertility clinics, reproductive centers, and fertility specialists leverage ART technologies to provide comprehensive services, including infertility testing diagnosis, fertility medications, and embryo transfer. Fertility apps and tracking tools facilitate patient engagement and support, while reproductive endocrinology continues to unravel the complexities of human reproduction. Environmental toxins and age-related infertility are emerging challenges, prompting ongoing research in stem cell research and reproductive medicine. The market landscape remains dynamic, with ongoing advancements in ART technologies and applications, ensuring a continuous unfolding of market activities.

How is this Assisted Reproductive Technology (ART) Industry segmented?

The assisted reproductive technology (ART) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-User

  Fertility clinics
  Hospitals
  Surgical centers
  Research institutes/labs
  Cryobanks


Type

  IVF
  Artificial Insemination
  GIFT (Gamete Intrafallopian Transfer)
  ZIFT (Zygote Intrafallopian Transfer)
  Surrogacy
  Donor egg/sperm ART


Product

  Instrument
  Accessory and Disposable
  Reagents and Media
  Software


Geography

  North America

    US


  Europe

    France
    Germany
    Netherlands
    UK


  Middle East and Africa

    UAE


  APAC

    China
    India
    Japan


  South America

    Brazil


  Rest of World (ROW)

By End-User Insights

The fertility clinics segment is estimated to witness significant growth during the forecast period.

Request Free Sample

Fertility clinics lead the assisted reproductive technology (ART) market, driven by a global surge in fertility centers addressing the rising demand from infertility patients. The success rates of these clinics measured by pregnancies or live births per treatment annually-are pivotal, boosting their reputation as top fertility treatment destinations in both domestic and international markets. Enhanced infrastructure in fertility clinics supports medical tourism for infertility treatment and drug though demand fluctuates due to economic factors, exchange rates, and external factors during 2025-2029. Organizations like ESHRE, ASRM, and ICMART work to standardize fertility tourism, minimizing exploitation and risks. However, stringent regulations pose challenges, with non-compliance le

In 2024 the infant mortality rate in Europe was estimated to be 3.4 per 1,000 live births compared with 82.2 in 1950. The infant mortality rate in Europe steadily decreased over this time period.

Snapshot img

Sperm Analytical Devices Market 2024-2028

The global sperm analytical devices market size is estimated to grow by USD 84.26 million, at a CAGR of 6.42% between 2023 and 2028.

The market is experiencing robust growth, driven by an increasing awareness of reproductive health worldwide. As societies become more informed and proactive about healthcare, there is a notable surge in individuals and couples seeking comprehensive fertility assessments. This heightened awareness is fueled by educational initiatives, public health campaigns, and the accessibility of information through various channels. Further, healthcare providers, fertility clinics, and diagnostic laboratories are responding to this awareness by integrating advanced sperm analytical devices into their services, offering precise evaluations of sperm parameters. These devices empower individuals and couples with valuable insights into their reproductive potential, reflecting a proactive approach toward reproductive health and family planning in the current informed society. Therefore, increasing awareness of reproductive health is poised to drive the growth of the market during the forecast period.

Technavio has segmented the market into End-user, Product, and Geography

The end-user segment includes hospitals, fertility clinics, and research and diagnostic laboratories
The product segment includes analyzer, disposable semen analysis devices, flow cytometer, and others
The geography segment includes key regions such as Europe, North America, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segemtation

End-user Analysis

The market share growth by the hospitals segment will be significant during the forecast period. The utilization of sperm analytical devices in hospitals has significantly transformed the landscape of reproductive healthcare. These devices, designed for comprehensive sperm analysis, have become integral tools in hospital settings, contributing to advanced diagnostics and personalized treatment plans for individuals facing fertility challenges. The controlled and sterile environments of hospitals provide an ideal setting for the precise examination of sperm parameters, such as concentration, motility, and morphology.

Get a glance at the market contribution of various segments Download PDF Sample

The hospitals segment was the largest and was valued at USD 96.38 million in 2018. The continuous advancements in sperm analytical device technology, with features like automation and enhanced data analysis capabilities, further solidify their place within hospital settings. This integration not only facilitates accurate diagnoses but also aligns with the broader trend of incorporating cutting-edge technologies into various medical specialties. As hospitals continue to prioritize comprehensive reproductive healthcare, the use of sperm analytical devices remains a driving force in enhancing the efficiency and effectiveness of fertility treatments. These factors are expected to drive the growth of the hospital segment of the market during the forecast period.

Product Analysis

Sperm analytical devices play a crucial role in assessing male reproductive health and fertility. These devices, often referred to as sperm analyzers, utilize advanced technology to examine various parameters of sperm, providing valuable insights for both clinicians and individuals seeking to understand fertility issues. One key feature of these analyzers is their ability to assess sperm concentration, motility, and morphology. By analyzing these aspects, clinicians can evaluate the overall quality of sperm, helping to diagnose potential fertility problems. Additionally, some sperm analyzers offer features such as real-time video analysis and automatic sample processing. Real-time monitoring allows for a dynamic evaluation of sperm behavior, while automated processing streamlines the workflow for laboratory professionals. These advancements contribute to a more comprehensive understanding of male reproductive health, facilitating personalized treatment plans for couples struggling with infertility. These factors are expected to drive the growth of the analyzers segment of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

Europe is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. In Europe, many factors contribute to falling fertility rates among men, such as

Over the past decade, the birth rate in Italy has constantly decreased – in 2024, 6.3 children were estimated to be born per 1,000 inhabitants, three infants less than in 2002. The region with the highest birth rate in the country was Trentino-South Tyrol, where 7.6 children were born per 1,000 residents. Italian mothers are older and older Similar to citizens of other European countries, Italians also postpone parenthood to a later age. While the average age of an Italian mother at childbirth in the 1990s was 29.9 years, in 2024 females giving birth were roughly 32.6 years. Italy, a country with one of the lowest fertility rates in the world If compared with the fertility rates around the world, Italy was one of the 20 countries which registered the lowest fertility rate in 2024. The leader of the global ranking was Taiwan, where only 1.11 babies were born per woman.